Injection
Compounded Tirzepatide injection
Learn which product your clinician is discussing, why they are considering it and how they would review your progress.

Compounded medicines are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before marketing. Package images are illustrations. Read the FDA’s guidance.
Identify the specific product
Tirzepatide acts on two hormone receptors called GIP and GLP-1. Zepbound is one FDA-approved injectable product containing tirzepatide. Ask your clinician to write down the product name and the condition they are considering it for.
Discuss what matters for you
Bring your current medicines and any questions about previous treatment. Ask what would lead the clinician to recommend another option, which effects to watch for and who to contact between appointments.
If the proposal involves compounding
A compounded product does not have FDA approval. Ask which medical need an approved option cannot meet and which licensed pharmacy would prepare the prescription.
Explore other injectables

Injection
Compounded Semaglutide injection
An ingredient may appear in several products. Start with the prescription name and the reason your clinician is considering it.

Growth hormone–releasing peptide
Compounded Sermorelin injection
A separate hormone-related topic. Understanding why sermorelin came up is the first question to bring to a clinician.